A digital revolution
A person-centric approachGSK, Stevenage
26 November 2024
Advanced Therapies Integrates Leadership Team and Advisory Board
The Executive Advisory Board is ideally placed to provide expert insight into the critical issues and challenges facing the Advanced Therapies industry today. Together they bring a wealth of first-hand experience and knowledge, sharing our determination to encourage further collaboration amongst key stakeholders shaping the future of the Advanced Therapies and ATMP industry.
We have assembled a group of renowned experts from across the sector. Kindly contact Christopher Watt or Samuel Thangiah if you would like to be considered for the Advanced Therapies Advisory Board.
SHARON BROWNLOW
(Chair)
Chief Business Officer
Cell and Gene Therapy Catapult
ANDREW FARQUHARSON
Executive Director
LifeArc
SALLY ANN FORSYTH OBE
Chief Executive Officer
Stevenage Bioscience Catalyst
JESÚS ZURDO
Global Head Cell, Gene Therapy & Bioproduction
Horizon Discovery
MARTINO PICARDO
Chairman
Discovery Park
BRIAN MULLAN
Head of Innovation, Analytical and Process Development – Cell and Gene Therapies
Yposkesi
SVEN KILI
Chief Executive Officer
Antion Biosciences
JASON FOSTER
Chief Executive Officer and Executive Director
Ori Biotech
FRANCESCA GLIUBICH
Director
London Advanced Therapies
STUART FORBES
Professor of Transplantation and Regenerative Medicine
University of Edinburgh
A digital revolution
A person-centric approach